Cullgen rakes in $50m Series B
Cullgen Inc., a biotechnology company, has raised $50 million in Series B financing.
Cullgen Inc., a biotechnology company, has raised $50 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination